Skip to main content
VCbacked
Log inGet Started

Soley Therapeutics

San Francisco, United States

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.

$200.0M raised
Jan 2026
Series C
BiotechnologyHealth CareTherapeutics

Top Investors

Doug Leone Family FundHRTG PartnersBreyer CapitalSurveyor CapitalGordonMD Global Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Soley Therapeutics

How much funding has Soley Therapeutics raised?
Soley Therapeutics has raised $200.0M in total funding. The most recent round was Series C. The last funding was announced in January 2026.
Who are Soley Therapeutics's investors?
Soley Therapeutics's investors include Doug Leone Family Fund, HRTG Partners, Breyer Capital, Surveyor Capital, GordonMD Global Investments.
Where is Soley Therapeutics headquartered?
Soley Therapeutics is headquartered in San Francisco, United States.
What does Soley Therapeutics do?
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
What stage is Soley Therapeutics at?
Soley Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Soley Therapeutics — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/soley-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2026). Soley Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/soley-therapeutics
Wikipedia (cite web)
{{cite web |title=Soley Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/soley-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong